Article

FDA clears normative database for OCT device

The FDA has given 510(k) clearance to a normative database for a proprietary optical coherence tomography device (RTVue, Optovue).

Fremont, CA-The FDA has given 510(k) clearance to a normative database (NDB) for a proprietary optical coherence tomography (OCT) device (RTVue, Optovue), according to the company.

“This [clearance] affirms that our protocols and management of this large international, multi-site normative population are at the level that FDA regulatory guidelines require,” said Mike Sinai, PhD, senior director of clinical research for Optovue. “Most importantly, this [clearance] demonstrates the safety and efficacy of our NDB based on FDA current standard for its intended uses. This is the only NDB taking into account patient age, signal strength of scan, and even optic disc size in certain scan type.”

The NDB comprises more than 600 eyes for the pending U.S. release and is the largest FDA-cleared NDB for an OCT device, according to the company. Optovue plans to release the OCT application update containing the newly cleared NDB for customers soon.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
© 2025 MJH Life Sciences

All rights reserved.